Deltec Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Deltec Asset Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20,000	Closed	-$68K	–	207
2018 Q3	$68K	Hold	20,000	–	–	0.01%	171
2018 Q2	$75K	Hold	20,000	–	–	0.02%	166
2018 Q1	$82K	Hold	20,000	–	–	0.02%	175
2017 Q4	$93K	Hold	20,000	–	–	0.02%	166
2017 Q3	$142K	Hold	20,000	–	–	0.03%	159
2017 Q2	$145K	Hold	20,000	–	–	0.03%	152
2017 Q1	$123K	Hold	20,000	–	–	0.03%	158
2016 Q4	$117K	Hold	20,000	–	–	0.03%	150
2016 Q3	$106K	Hold	20,000	–	–	0.02%	148
2016 Q2	$132K	Sell	20,000 -20,000	-50%	-$112K	0.03%	135
2016 Q1	$187K	Buy	40,000 +20,000	+100%	+$79.8K	0.05%	128
2015 Q4	$101K	Buy	+20,000	New	+$95K	0.03%	140

Deltec Asset Management's KERX Position: Q4 2018 in Review

Deltec Asset Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 20,000 shares — an estimated $68K sold.

Deltec Asset Management first reported a position in KERX in Q4 2015 and held it in 12 quarters. The position peaked at $187K in Q1 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Deltec Asset Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Deltec Asset Management sold 20,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $68K.
Deltec Asset Management first reported a position in Keryx Biopharmaceuticals Inc in Q4 2015 and held it in 12 quarters.
Deltec Asset Management's Keryx Biopharmaceuticals Inc position peaked at $187K in Q1 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Deltec Asset Management's 13F filing for Q4 2018, filed 23 Jan 2019.